Freddy White

Freddy White has a diverse work experience starting from 2005. Freddy began their career in the entertainment industry, working with Paines Plough Theatre Company in 2005, the National Theatre in 2006, and the Royal Shakespeare Company in 2007.

In 2009, Freddy transitioned into the publishing industry as a Sales Director for European Pharmaceutical Review & Drug Target Review at Russell Publishing. During their tenure, they successfully transformed the failing European Pharmaceutical Review into a profitable media brand, incorporating events and digital services.

In 2014, Freddy joined Clarion Events as the Chief Commercial Officer, where they played a key role in the launch and development of Front Line Genomics, a publishing and events series. Freddy gained valuable experience working with event teams and reporting to Clarion's CEO, Russell Willcox.

Most recently, in 2017, Freddy became the CEO of AIMed, a medical innovation institute focused on translating Artificial Intelligence into Medicine. Freddy was inspired to join by Dr. Anthony Chang, a pediatric cardiologist and CIIO at the Children's Hospital of Orange County. Freddy's role involves exploring the potential of AI in healthcare and seeking knowledge from industry experts.

Overall, Freddy White's work experience showcases their adaptability, strong leadership skills, and ability to drive successful transformations in various industries.

Freddy White began their education in 1992 at Sylvia Young Theatre School, where they studied Performing Arts. Freddy attended the school for four years until 1996. Following this, from 1996 to 1998, Freddy attended Duff Miller where they focused on Theatre Studies. The information provided does not indicate any degrees obtained by Freddy during their education.